Acumen Pharmaceuticals (ABOS): Volume dana dhuwit perusahaan

Logo grafis Acumen Pharmaceuticals (ABOS)

Acumen Pharmaceuticals (ABOS) aims to capture the market through the development of the ACU193 drug. The model's efficiency is based on the full outsourcing of production and testing, which minimizes capital expenditures. Despite the dependence on R&D outcomes, the cash balance confirms financial stability, with its value recorded at 0.08, guaranteeing the company's liquidity.

ABOS - Dhuwit awis perusahaan Acumen Pharmaceuticals Inc. ing rentang 04.07.2022 - 21.11.2026

Rincian analitis perusahaan Acumen Pharmaceuticals

- nilai saham lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:acumenpharm.com
Sampel barang Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals (ABOS) requires colossal expenditures to develop unique antibodies against Alzheimer's disease, meaning the actual cash balance on the balance sheet determines the company's survival horizon until patent commercialization. By analyzing the history of cash flow changes, an investor assesses real liquidity and the business's ability to fund R&D without emergency loans, although excess reserves do not always guarantee effective market expansion.

Pesaing utama

Volume dana dhuwit perusahaan BIIB|Dana dhuwit perusahaan NBIX (Neurocrine Biosciences)|Dana dhuwit perusahaan Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Total volume dana dhuwit perusahaan|ACADIA Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Dhuwit awis perusahaan|Supernus Pharmaceuticals (SUPN) - Volume dana dhuwit perusahaan|CPRX (Catalyst Pharma) - Volume dana dhuwit perusahaan|DNLI (Denali Therapeutics Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan HRMY|Biohaven Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan AMLX (amylyx.com)|Aset likuid perusahaan Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Anavex|CBLL (CeriBell Inc) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PRTA|Dana dhuwit perusahaan Alector Inc.|Cadangan dhuwit perusahaan Annexon, Inc. ANNX|Dana dhuwit perusahaan Omeros Corp (OMER)|NGNE (Neurogene Inc) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan AC Immune Inc ACIU|Posisi dhuwit perusahaan Voyager Corp|Neumora Corp - Volume dana dhuwit perusahaan|scilexholding.com (SCLX) - Dhuwit awis perusahaan|Tevogen Bio Holdings, Inc. (TVGN) - Dana dhuwit perusahaan|Alpha Cognition Corp (ACOG) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan CGTX|Dhuwit awis lan setara dhuwit awis perusahaan IKT (Inhibikase)|Volume dana dhuwit perusahaan SAVA|Assertio - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan COYA (Coya Therapeutics)|Volume dana dhuwit perusahaan Vistagen Therapeutics VTGN|OVID: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan CervoMed Inc|alteritytherapeutics.com (ATHE) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Clene Nanomedicine|Dhuwit awis perusahaan PEPG|Cadangan dhuwit perusahaan Jupiter Neurosciences JUNS|Dana dhuwit perusahaan Relmada (RLMD)|Aset likuid perusahaan Annovis Bio, Inc.|Volume dana dhuwit perusahaan GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Cadangan dhuwit perusahaan|KLTO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan NeuroSense Therapeutics Ltd|RVPH: Volume dana dhuwit perusahaan|MetaVia, Inc. (MTVA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan NeurAxis|Volume dana dhuwit perusahaan heliusmedical.com|Dhuwit awis perusahaan PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Dhuwit awis lan setara dhuwit awis perusahaan|Minerva Neurosciences Corp - Dhuwit awis perusahaan|Sisa dhuwit perusahaan ATHA|ADXN - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PTIX|KTTA (pasitheaclinics.com) - Volume dana dhuwit perusahaan|CRGT (cortigent.com) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan ATXI|Dana dhuwit perusahaan BCLI (Brainstorm Cell)|Volume dana dhuwit perusahaan CARA (Cara Therapeutics Inc)|Sisa dhuwit perusahaan CHRO|Eliem Therapeutics Inc. - Volume dana dhuwit perusahaan|ITCI - Volume dana dhuwit perusahaan|Longboard Pharma (LBPH) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Marinus Pharmaceuticals|Dana dhuwit perusahaan NKGen|Volume dana dhuwit perusahaan NeuroBo Pharmaceuticals, Inc.|Volume dana dhuwit perusahaan SAGE|Synaptogenix, Inc - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Trevena TRVN|Posisi dhuwit perusahaan Vigil Neuroscience|Anew Medical Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan Cerevel Therapeutics, Inc. CERE